The CCG-AVB-TEP1 model proposed by Han (19) was based on non-TIPS cohorts (cirrhosis-related AVB patients who were treated with endoscopy plus drugs) and validated by a small sample of preemptive-TIPS cohorts. The gene discussed is TEP1; the disease is Cirrhosis.